Above Baseline — Drug development intelligence, above the noise.

Above Baseline Drug Dev Intel

Latest
My Picks
ADA & Immunogenicity
ADCs
PK/PD
Small Molecule

Uncategorized

Hello world!

April 11, 2026

Welcome to WordPress. This is your first post. Edit or delete it, then start writing!

← More in Uncategorized ← All stories

This Week's Digest

01

ADC linker stability in circulation remains the lead challenge this week.

02

FDA ADA guidance comment period — check regulations.gov for deadlines.

03

AAPS NBC 2026 abstract submissions open — check aaps.org.

04

LNP delivery getting renewed attention across mRNA and gene therapy programs.

Browse by Topic

ADA & Immunogenicity ADCs My Picks PK/PD Small Molecule

Pipeline Pulse

NDA submissions YTD 34

ADC programs in Ph I/II 112

FDA RTFs (Q1 2026) 8

Immunogenicity holds 3

© 2026 Above Baseline — Independent drug development news

About Submit / Contact